Kleanthis G. Xanthopoulos, Ph.D.
Chairman & Chief Executive Officer
STEVEN HOLTZMAN
Co-Founder & Director
Marios Fotiadis
Director
Shoreline Biosciences Is Positioned to Be a Category Leader
Our Vision
To advance transformative therapies for autoimmune disease and cancer
Our Mission
To develop the right cell, with the right edits, for the right indications
We Are Committed to Scientific and Clinical Excellence and Are Passionate About Bringing Transformative Therapies to Patients in Critical Need
Leadership Team
Mauro P. Avanzi, MD, Ph.D.,
Chief Medical Officer
Scott Forrest, Ph.D.
Chief Business Officer
Lyuda Hillman, CPA
Vice President, Controller
Leah Mitchell, Ph.D.
Vice President, Translational Pharmacology
Paschalis Sideras, PH.D.
Senior Vice President, Research
Kleanthis G. Xanthopoulos, Ph.D.
Chairman & Chief Executive Officer
Board of Directors
Christopher Fuglesang, Ph.D., J.D.
Director
Frank YU
Director
Scientific Advisory Board
William Sandborn, M.D.
Co-Founder & Advisory Board Member
Travis S. Young, Ph.d.
Advisory Board Member
Scott Antonia, M.D., Ph.D.
Advisory Board Member
SILKE PAUST, Ph.D.
Advisory Board Member
Judith Shizuru, M.D., Ph.D.
Advisory Board Member
Éric Vivier, DVM, Ph.D.
Advisory Board Member